Literature DB >> 17332240

Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis.

Ajaikumar B Kunnumakkara1, Asha S Nair, Kwang Seok Ahn, Manoj K Pandey, Zhengfang Yi, Mingyao Liu, Bharat B Aggarwal.   

Abstract

Gossypin, a flavone originally isolated from Hibiscus vitifolius, has been shown to suppress angiogenesis, inflammation, and carcinogenesis. The mechanisms of these activities, however, are unknown. Because nuclear factor-kappaB (NF-kappaB) is associated with inflammation, carcinogenesis, hyperproliferation, invasion, and angiogenesis, we hypothesized that gossypin mediates its effects through modulation of NF-kappaB activation. In the present study, we demonstrate that gossypin (and not gossypetin, an aglycone analog) inhibited NF-kappaB activation induced by inflammatory stimuli and carcinogens. Constitutive NF-kappaB activation in tumor cells was also inhibited by this flavone. Inhibition of I kappa B alpha kinase by gossypin led to the suppression of I kappa B alpha phosphorylation and degradation, p65 nuclear translocation, and NF-kappaB-regulated gene expression. This, in turn, led to the down-regulation of gene products involved in cell survival (IAP2, XIAP, Bcl-2, Bcl-xL, survivin, and antiFas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein), proliferation (c-myc, cyclin D1, and cyclooxygenase-2), angiogenesis (vascular endothelial growth factor), and invasion (matrix metalloprotease-9). Suppression of these gene products by gossypin enhanced apoptosis induced by tumor necrosis factor and chemotherapeutic agents, suppressed tumor necrosis factor-induced cellular invasion, abrogated receptor activator of NF-kappaB ligand-induced osteoclastogenesis, and vascular endothelial growth factor-induced migration of human umbilical vein endothelial cells. Overall, our results demonstrate that gossypin inhibits the NF-kappaB activation pathway, which may explain its role in the suppression of inflammation, carcinogenesis, and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332240      PMCID: PMC1890830          DOI: 10.1182/blood-2007-01-067256

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates.

Authors:  D K Giri; B B Aggarwal
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

3.  The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase.

Authors:  R Schwenzer; K Siemienski; S Liptay; G Schubert; N Peters; P Scheurich; R M Schmid; H Wajant
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

4.  Functional interactions of transforming growth factor beta-activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation.

Authors:  H Sakurai; H Miyoshi; W Toriumi; T Sugita
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

5.  Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons.

Authors:  M Tamatani; Y H Che; H Matsuzaki; S Ogawa; H Okado; S Miyake; T Mizuno; M Tohyama
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

Authors:  C Y Wang; M W Mayo; R G Korneluk; D V Goeddel; A S Baldwin
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

7.  Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.

Authors:  B G Darnay; J Ni; P A Moore; B B Aggarwal
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.

Authors:  L A Erickson; L Jin; J R Goellner; C Lohse; V S Pankratz; L R Zukerberg; G B Thompson; J A van Heerden; C S Grant; R V Lloyd
Journal:  Mod Pathol       Date:  2000-02       Impact factor: 7.842

9.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Authors:  Y Y Kong; H Yoshida; I Sarosi; H L Tan; E Timms; C Capparelli; S Morony; A J Oliveira-dos-Santos; G Van; A Itie; W Khoo; A Wakeham; C R Dunstan; D L Lacey; T W Mak; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

10.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

Authors:  W Wang; J L Abbruzzese; D B Evans; L Larry; K R Cleary; P J Chiao
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  19 in total

1.  Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.

Authors:  Simone Reuter; Subash C Gupta; Kanokkarn Phromnoi; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.

Authors:  Li Wang; Xiangyu Wang; Hanyong Chen; Xueyin Zu; Fayang Ma; Kangdong Liu; Ann M Bode; Zigang Dong; Dong Joon Kim
Journal:  Phytother Res       Date:  2018-12-10       Impact factor: 5.878

3.  Gossypin induces G2/M arrest in human malignant glioma U251 cells by the activation of Chk1/Cdc25C pathway.

Authors:  Lei Shi; Jian Chen; Yin-yi Wang; Guan Sun; Jing-ning Liu; Jun-xia Zhang; Wei Yan; Chun-fa Qian; Ning Liu; Zhen Fu; Yong-ping You; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2011-10-09       Impact factor: 5.046

4.  Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.

Authors:  Hemachander Capiralla; Valérie Vingtdeux; Haitian Zhao; Roman Sankowski; Yousef Al-Abed; Peter Davies; Philippe Marambaud
Journal:  J Neurochem       Date:  2011-12-16       Impact factor: 5.372

5.  Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Kwang S Ahn; Preetha Anand; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

6.  Inhibition of IkB kinase and NF-kappaB by a novel synthetic compound SK 2009.

Authors:  Ravi Kumar Anchoori; Kuzhuvelil B Harikumar; Venkateswara Rao Batchu; Bharat B Aggarwal; Saeed R Khan
Journal:  Bioorg Med Chem       Date:  2009-11-04       Impact factor: 3.641

Review 7.  NF-kappaB and cancer: how intimate is this relationship.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bharat B Aggarwal
Journal:  Mol Cell Biochem       Date:  2009-10-08       Impact factor: 3.396

8.  Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.

Authors:  Preetha Anand; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Kwang Seok Ahn; Vladimir Badmaev; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

9.  Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells.

Authors:  Hua Xiong; Zhi-Gang Zhang; Xiao-Qing Tian; Dan-Feng Sun; Qin-Chuan Liang; Yan-Jie Zhang; Rong Lu; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

Review 10.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.